Position in GRFS
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$90,631
-$88,599 QoQ
Shares Held
12,801
-42.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#98
of 164 holders
Holding Since
Dec 2024
5 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026EVERGREEN CAPITAL MANAGEMENT LLC holds $119,428,715 across 15 Drug Manufacturers - General names. GRFS ranks #15 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
258,518 | $33,219,563 | |
| 2 | JNJ |
Johnson & Johnson
|
66,225 | $16,819,162 | |
| 3 | LLY |
ELI LILLY & Co
|
12,152 | $14,575,473 | |
| 4 | ABBV |
AbbVie Inc.
|
51,916 | $13,064,141 | |
| 5 | PFE |
Pfizer Inc
|
506,065 | $12,186,044 | |
| 6 | NVS |
Novartis AG
|
45,908 | $7,194,701 | |
| 7 | AZN |
Astrazeneca PLC
|
32,180 | $6,101,971 | |
| 8 | NVO |
Novo Nordisk A S
|
85,847 | $4,115,504 |
All Filings in GRFS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $90,631 | 12,801 | Shares | Other | 2026-07-23 | |
| 2026-03-31 | $179,230 | 22,348 | Shares | Other | 2026-05-14 | |
| 2025-12-31 | $204,325 | 21,853 | Shares | Other | 2026-01-27 | |
| 2025-03-31 | $103,102 | 14,501 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $113,839 | 15,301 | Shares | Other | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||